Financial Data and Key Metrics Changes - The company reported third quarter GAAP net sales of $542 million, a 49% decrease year-over-year, primarily due to significant long-term actions taken in India [4][16] - Adjusted EBITDA was $236 million, reflecting a 17% increase year-over-year on an as-reported basis and a 23% increase on a like-for-like basis [9] - Adjusted EPS was $0.89, up 30% from the prior year, driven by higher adjusted EBITDA [9] Business Line Data and Key Metrics Changes - Excluding India, third quarter revenue was $961 million, down 4% year-over-year on a like-for-like basis, driven by a 6% price decline [5] - The company's growth portfolio increased by mid-single digits, with sales of new active ingredients nearly doubling compared to the prior year [5] - Sales in Latin America lagged by 8% year-over-year, attributed to low liquidity and pricing pressure from generics [6][8] Market Data and Key Metrics Changes - The market landscape in Latin America is challenging due to constrained credit for customers in Brazil and Argentina and increased competition from generics [3][6] - Sales improved in North America and EMEA, driven by higher volumes, including contributions from the recent launch of Isoflex™ Active in Great Britain [8] - The company observed generic pressure in Asia and to a lesser extent in North America and EMEA [8] Company Strategy and Development Direction - The company is focusing on being a pure play agricultural sciences company and has a strong pipeline of innovative technologies [3] - A strategic review of the manufacturing footprint is underway to transition production to lower-cost sources [13] - The company aims to become cost-competitive while growing a portfolio of IP-protected products that command higher margins [14] Management's Comments on Operating Environment and Future Outlook - Management expects the challenging conditions observed in Q3 to continue into Q4, with anticipated sales excluding India in the range of $1.12 billion to $1.22 billion [10] - The company is adjusting its full-year guidance to reflect lower sales and EBITDA expectations, with revenue now expected between $3.92 billion and $4.02 billion [11] - Management acknowledges the need for a disciplined approach to cost control and pricing to navigate the current market challenges [9][12] Other Important Information - Free cash flow guidance has been lowered to a range of negative $200 million to $0, driven by lower cash from operations [12][23] - The company has initiated a significant reduction in its quarterly dividend, which will reduce the funding need for the dividend by $250 million in 2026 [24] - The company is taking immediate actions to amend financial covenants to provide additional flexibility [24] Q&A Session Summary Question: Can you talk about the buckets of what's eating up that cash flow? - Management indicated that the primary issue is lower sales leading to reduced collections, compounded by liquidity constraints affecting cash sales [32][34] Question: What do you expect the sale price for the India business might be? - The estimated value of the India business is about $450 million, with strong interest from local and international companies [40][41] Question: How do you remain committed to the investment-grade rating? - Management is focused on reducing cash use for dividends to allow for debt repayment and restructuring costs, aiming to return to healthier metrics over time [49][50] Question: How much of your portfolio is reassessing production costs? - The company is starting to reassess its manufacturing portfolio, with some products being candidates for relocation to lower-cost sources [70] Question: Are you considering partnerships or acquisitions? - Management believes partnerships will be increasingly important, especially in technology, but is not currently considering selling any active ingredients close to commercialization [79][97]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 decreased by 11.5%, or 5% when excluding the impact of Political, The Daily Wire, and The Dan Bongino Show, consistent with prior guidance [5][18] - EBITDA for the quarter was reported at $16.7 million [18] - Digital revenue increased by 8% year-over-year, excluding the impact of The Daily Wire and Dan Bongino, with Digital Marketing Services growing by 34% [18] Business Line Data and Key Metrics Changes - Broadcast spot revenue market share grew for the third consecutive quarter, indicating strong sales execution and local programming [5] - Digital Marketing Services business saw a 34% year-over-year growth, driven by an 88% increase in new accounts and an 8% increase in campaign order size [7] - Podcasting revenue increased by 15% year-over-year, contributing to an overall digital revenue growth of over 8% when normalized [8] Market Data and Key Metrics Changes - In Dallas, the largest market, the company gained almost 4 points of market share, with total revenue up mid-single digits while peers were down nearly 10% [9] - National advertising environment remained weak, leading to a 27% decline in total network revenue, although market share was gained year-to-date [10] Company Strategy and Development Direction - The company is focused on leveraging core competencies and valuable assets, including a vast audience reach and established client relationships [15] - Plans to launch the Westwood One Sports 24/7 Network to capitalize on strong consumer brand recognition and digital distribution opportunities [11] - Continued investment in Digital Marketing Services is expected to yield strong returns, with a focus on AI-driven projects to enhance efficiency and growth [12][13] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing headwinds in the broadcast radio sector but expressed confidence in outperforming peers through strategic execution [15] - The company anticipates continued revenue pacing down mid-single digits, excluding political impacts, and down mid to high teens when including those impacts [12][20] Other Important Information - The company ended the quarter with $90 million in cash and $109 million in total liquidity, with a debt maturity of $697 million [19] - A litigation against Nielsen was acknowledged, with a preliminary injunction hearing scheduled for early December [16] Q&A Session Summary - No specific questions or answers were documented in the provided content, indicating a lack of detailed Q&A during the call [21][22]

Industry Trend - Hollywood is seeking Silicon Valley partnerships to accelerate TV and movie production and decrease expenses [1] Cost Reduction - The venture aims to reduce the time and money required for Hollywood productions [1]

Core Viewpoint - APA Corporation is expected to report third-quarter results on November 5, with an estimated earnings per share of 74 cents and revenues of $2.04 billion, reflecting a decline in revenues compared to the previous year [1][8]. Group 1: Previous Performance - In the last reported quarter, APA exceeded consensus estimates with adjusted earnings per share of 87 cents and revenues of $2.6 billion, surpassing the Zacks Consensus Estimate by over 26% [2]. - The company has had mixed results in the past four quarters, beating estimates in two and missing in the other two, resulting in an average surprise of 24.89% [3]. Group 2: Revenue and Earnings Estimates - The Zacks Consensus Estimate for third-quarter 2025 earnings indicates a 26% decline year over year, while revenues are expected to decrease by 19.52% compared to the previous year [3][8]. - Revenues from APA's core oil, natural gas, and natural gas liquids segment are projected to drop by 26.1% year over year, with a 27.2% decline in revenues from purchased oil and gas sales [5]. Group 3: Cost Management - APA's total expenses are anticipated to reach $1.46 billion in the third quarter, representing a 49.2% decrease from the same period last year [6][8]. - Significant reductions in costs are expected across key segments, including lease operating expenses, which are projected to fall from $418 million to $405 million, and gathering, processing, and transmission costs, expected to decline from $123 million to $95.4 million [6].

Core Insights - United Parcel Service (UPS) exceeded analysts' profit expectations for Q3 and forecasted revenue above Wall Street's expectations for the holiday season, relying on price increases to counteract weak business-to-business demand in the U.S. [1][2] - UPS's shares rose 8.9% in premarket trading, while rival FedEx gained 2.5%. However, UPS shares have declined approximately 28% since the beginning of the year [1]. Financial Performance - UPS projected fourth-quarter revenue to be around $24 billion, surpassing analysts' average expectation of $23.8 billion [2]. - The company reported an adjusted profit of $1.74 per share for the three months ending September 30, exceeding analysts' average expectation of $1.30 [6]. - Consolidated revenue for UPS was $21.41 billion, above the expected $20.83 billion [6]. - The adjusted consolidated operating margin was 10%, an increase from 8.8% in Q2, while the domestic segment margin decreased to 6.4% from 7% in Q2 [7]. Strategic Initiatives - UPS is focusing on rate hikes, cost reductions, and prioritizing high-margin shipments to stabilize its business ahead of the holiday season [3]. - The company is reducing the number of packages delivered for its largest customer, Amazon, to enhance profit margins [4]. - UPS is undergoing a significant overhaul to cut $3.5 billion in costs by 2025, which includes closing hundreds of facilities and reducing its workforce [6]. Market Context - The peak holiday shipping season, when UPS's daily average volumes can double, runs from November to the end of January [5].

Core Viewpoint - Procter & Gamble (PG) is experiencing fluctuations in its consensus price target, reflecting changes in analyst expectations and company performance [1][2][5] Price Target Analysis - The average price target for PG decreased from $168.25 in the previous quarter to $164.5, indicating a downward trend in analyst expectations [2][5] - Deutsche Bank has set a price target of $177, suggesting a more optimistic outlook compared to the average [2] Earnings and Performance Outlook - PG is set to release its first-quarter earnings on October 24, with expectations on the lower side due to recent performance [3] - The company is actively working on cost reduction and revamping its cost base, which may enhance long-term performance [3][5] Market Position and Growth Potential - PG has underperformed relative to the S&P 500 and its staple peers, but there is potential for recovery and above-average market growth [4][5] - Despite expected declines in Q1 earnings, PG's strategic initiatives and earnings reports are crucial for assessing future performance [4][5]

Financial Data and Key Metrics Changes - The company reported a decline in sales and brand partner productivity leading up to the global convention in August, but recent activity has shown improvement [4][7] - An increase in inventories was noted, attributed to new product introductions and investments in inventory locations for tariff mitigation [8] - The company expects to incur a one-time charge of $4.7 million in the fourth quarter due to a global cost reduction process [12] Business Line Data and Key Metrics Changes - Hiya Health experienced a 26% year-to-date sales growth despite challenges in the third quarter, with significant progress in integration initiatives [9] - RiseBar reported record third quarter net sales, with year-to-date net sales increasing by 169% [10][11] - The company is investing additional resources in Hiya Health and RiseBar to capitalize on current momentum and drive long-term growth [11] Market Data and Key Metrics Changes - The Americas and Europe regions performed relatively better than other regions, partly due to the performance of RiseBar [23] - The direct selling business has struggled over the past few years, but recent enhancements in offerings are expected to improve performance [34] Company Strategy and Development Direction - The company is focused on a comprehensive commercial strategy that includes an enhanced compensation plan, product innovation, and improved tools for brand partners [4][6] - Diversification is a key part of the company's strategy, with ongoing growth in Hiya Health and RiseBar [13][38] - The company plans to continue investing in its commercial strategy and explore M&A opportunities to expand its portfolio [39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth potential of the direct selling business and the diversification strategy [13] - The company is optimistic about the future, citing renewed excitement and engagement from brand partners following the compensation plan enhancements [7][20] - The broader industry has faced challenges, but there is a positive outlook due to increasing consumer awareness of the importance of supplements [34][51] Other Important Information - The company has initiated a global cost reduction process, including right-sizing its workforce to prioritize strategic goals [11][12] - Management is focused on improving operational efficiencies and margins through in-house manufacturing capabilities for Hiya Health products [10][31] Q&A Session Summary Question: Can you walk us through the trajectory of your business trends from July through October? - Management noted promising trends from the new compensation plan launched in July, with increased engagement and excitement among brand partners [18][19] Question: Why did the Americas and Europe region perform better? - The performance was attributed to the global convention and the contribution from RiseBar, which has seen improved sales [23] Question: What incentives are planned for the fourth quarter? - The company plans to provide strategic incentives for brand partners, which will likely carry over into early 2026 [24] Question: What are the reasons for the decline in Hiya Health's active customer count? - Management acknowledged challenges due to changes in Meta's algorithms but remains confident in Hiya's growth potential [25] Question: What are the expected annualized operating cost savings from the right-sizing process? - Management indicated that it is early in the process and will provide more details in February [27] Question: Are there opportunities for further DTC acquisitions? - The company is committed to diversification and will explore M&A opportunities to strengthen its portfolio [38]

Financial Data and Key Metrics Changes - In Q3, the company reported net sales of $10 billion, with EBITDA at $868 million, reflecting a sequential improvement despite being lower than the same period last year [5][6][7] - Cash provided by operating activities increased by $1.6 billion sequentially, driven by working capital improvements and advanced payments for low-carbon solutions [7][16] Business Line Data and Key Metrics Changes - The packaging and specialty plastics segment saw net sales decline year-over-year and sequentially, with operating EBIT at $199 million, primarily due to lower integrated margins [11][12] - The industrial intermediates and infrastructure segment experienced a 4% year-over-year decline in net sales but saw a sequential increase due to volume gains and lower planned maintenance activity [12][13] - Performance materials and coatings segment net sales were $2.1 billion, down 6% year-over-year and 2% sequentially, with operating EBIT decreasing due to upstream margin compression [14] Market Data and Key Metrics Changes - Global demand in the packaging market remains steady, with North America experiencing record domestic and export volumes, while Europe contracted [18][19] - The infrastructure sector faces soft market conditions across the U.S., Europe, and China, with mortgage rates in the U.S. remaining above 6% [18][19] Company Strategy and Development Direction - The company is focused on restoring core earnings and positioning for profitable growth, with over $6.5 billion in strategic actions and cash support planned [32][33] - The company is committed to being a low-cost producer, with over 75% of its global cracking capacity in a top-quartile cost position, expected to increase to approximately 80% [29][30] Management's Comments on Operating Environment and Future Outlook - Management noted a cautious operating environment with subdued business investment and consumer spending due to economic uncertainty, but anticipates potential positive influences from recent monetary policy shifts [18][21] - For Q4, the company expects EBITDA to be approximately $725 million, with anticipated headwinds from higher feedstock costs and normal seasonality impacting performance [21][22] Other Important Information - The company has completed significant strategic actions, including a $3 billion partnership for U.S. Gulf Coast infrastructure assets and a $1.4 billion bond issuance for financial flexibility [8][16] - The company is on track to deliver approximately $400 million in targeted cost savings this year, contributing to improved performance [9][10] Q&A Session Summary Question: Reconciliation of Q3 results - Management highlighted higher integrated margins and better-than-expected volume as key factors for exceeding expectations in Q3 [37][39] Question: Rationalization and project cancellations - Management provided insights on global capacity rationalization, particularly in ethylene supply, and noted potential delays in announced capacity in China due to market conditions [44][46] Question: Polyethylene demand - Polyethylene demand has remained stable, with strong performance in packaging and personal care segments, and expectations for continued stability [62][63] Question: Demand function and order books - October order books appear positive, with management maintaining a balanced outlook for Q4 sales and EBITDA guidance [73][75]

3Q 2025 Results October 23, 2025 Agenda ▪ 3Q25 Highlights ▪ Operating Segment Performance ▪ Actions to Provide Greater Financial Flexibility and Improved Profitability ▪ Outlook ▪ Industry Opportunities Non-GAAP measures are defined in the appendix 3Q 2025 Highlights Delivered Solid Results, Cost Savings Actions, and Near-Term Cash Support 3 $10.0B Net Sales $868MM Operating EBITDA $249MM Returned to Shareholders ▪ Operating EBITDA was $868MM, up $165MM QoQ ▪ Total CapEx for the quarter was $564MM ▪ Cash Fl ...

Accessibility StatementSkip Navigation MIDLAND, Mich., Oct. 23, 2025 /PRNewswire/ -- Dow (NYSE: DOW):Â 3Q25 FINANCIAL HIGHLIGHTS SUMMARY FINANCIAL RESULTSÂ | Three Months Ended Sep 30 | Three Months Ended Jun 30 | | | | | | --- | --- | --- | --- | --- | --- | | | | | vs. | | vs. | | | | | SQLY | | PQ | | In millions, except per share amounts | 3Q25 | 3Q24 | | 2Q25 | | | | | | [B / | | [B / | | | | | (W)] | | (W)] | | Net Sales | $9,973 | $10,879 | $(906) | $10,104 | $(131) | | GAAP Income (Loss) Net of Tax ...